Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection by Zeis, Thomas et al.
Normal-appearing white matter in multiple
sclerosis is in a subtle balance between
inflammation and neuroprotection
Thomas Zeis,1Ursula Graumann,1 Richard Reynolds2 and Nicole Schaeren-Wiemers1
1Neurobiology, Department of Research, University Hospital Basel, Pharmacenter, Basel, Switzerland and 2Department of
Cellular & Molecular Neuroscience, Division of Neuroscience, Imperial College, Charing Cross Hospital Campus,
LondonW6 8RP, UK
Correspondence to: Nicole Schaeren-Wiemers, Neurobiology, Department of Research, Pharmacenter 7007,
Klingelberstrasse 50, CH-4056 Basel, Switzerland
E-mail: nicole.schaeren-wiemers@unibas.ch
Multiple sclerosis is a chronic inflammatory disease of the CNS. Although progressive axonal injury and diffuse
inflammatory damage has been shown in the chronic phase of the disease, little is known about the molecular
mechanisms underlying these pathological processes. In order to identify these mechanisms, we have studied
the gene expression profile in non-lesion containing tissue, the so-called normal-appearing white matter
(NAWM). We performed differential gene expression analysis and quantitative RT-PCR on subcortical white
matter from 11 multiple sclerosis and 8 control cases. Differentially expressed genes were further analysed in
detail by in situ hybridization and immunofluorescence studies.We show that genes known to be involved in
anti-inflammatory and protective mechanisms such as STAT6, JAK1, IL-4R, IL-10, Chromogranin C and Hif-1a
are consistently upregulated in the multiple sclerosis NAWM.On the other hand, genes involved in pro-inflam-
matory mechanisms, such as STAT4, IL-1b and MCSF, were also upregulated but less regularly.
Immunofluorescence colocalization analysis revealed expression of STAT6, JAK1, IL-4R and IL-13R mainly in oli-
godendrocytes, whereas STAT4 expression was detected predominantly in microglia. In line with these data,
in situ hybridization analysis showed an increased expression in multiple sclerosis NAWMof HIF-1a in oligoden-
drocytes and HLA-DRa in microglia cells. The consistency of the expression levels of STAT6, JAK1, JAK3 and
IL-4R between the multiple sclerosis cases suggests an overall activation of the STAT6-signalling pathway in
oligodendrocytes, whereas the expression of STAT4 and HLA-DRa indicates the activation of pro-inflammatory
pathways in microglia.The upregulation of genes involved in anti-inflammatorymechanisms driven by oligoden-
drocytes may protect the CNS environment and thus limit lesion formation, whereas the activation of
pro-inflammatory mechanisms in microglia may favour disease progression. Altogether, our data suggests an
endogenous inflammatory reaction throughout the whole white matter of multiple sclerosis brain, in which oli-
godendrocytes actively participate. This reaction might further influence and to some extent facilitate lesion
formation.
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Introduction
Multiple sclerosis (MS) is a chronic inflammatory
demyelinating disease of the CNS. Studies of the histo-
pathology of the demyelinated lesions characteristic of
this disease (Raine and Scheinberg, 1988; Lucchinetti et al.,
2000) have revealed a great deal of heterogeneity at
the cellular and molecular level, which might partially
reflect the diversity of the clinical disease course. A major
effort in the study of the pathogenesis of MS has been
to understand the molecular mechanisms of lesion forma-
tion (Lucchinetti et al., 2000; Lock et al., 2002), and in
particular the role of various immune-modulating compo-
nents in the different types of lesions (Lassmann and
Ransohoff, 2004).
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Pathological similarities to the animal model for
Th1-mediated brain inflammation, experimental autoim-
mune encephalomyelitis (EAE), have suggested that MS is
an autoimmune disorder caused by myelin-specific CD4+
T cells of the Th1 (Lassmann and Ransohoff, 2004;
Sospedra and Martin, 2005) and/or Th17 type (Gutcher et
al., 2006; Weaver et al., 2006). In contrast, other studies
have highlighted a major role for CD8+ T cells in EAE and
MS (Booss et al., 1983; Babbe et al., 2000; Sun et al., 2001;
Neumann et al., 2002). Furthermore, Th2 helper-cell-
mediated mechanisms have also been suggested to con-
tribute to inflammation in a subset of patients with MS
(Lafaille et al., 1997). Cytokines are critical components in
immune regulation and signalling, and thus, play a major
role in determining the actions of different immune cells.
Although still debated, anti-inflammatory cytokines of the
Th2 type (e.g. Il-10, IL-4) are thought to be mostly
beneficial and have been associated with remissions and
recovery from disease (Cannella and Raine, 2004; Sospedra
and Martin, 2005). In contrast, cytokines of the Th1 and
Th17 type (e.g. Il-1, IL-6, IL-12, IL-17, IFN-g and TNF-b)
are thought to be predominantly pro-inflammatory and are
likely to play a role in the pathogenesis of MS. In regard to
CNS-Immune system communication cytokines are highly
relevant as well. As an example CNS-targeted expression of
IL-3 is sufficient to promote recruitment and activation
of macrophage/microglial cells in white matter regions of
the brain leading to subsequent demyelination (Chiang
et al., 1996), highlighting the crucial role of CNS specific
modulation of the immune system.
There is accumulating evidence for the disregulation of
various aspects of the immune response in the brain paren-
chyma as well as in the periphery in MS. An important signal
transduction pathway involved in immune regulation is the
JAK/STAT-signalling pathway, which consists of the protein
families of Janus tyrosine kinases (JAK) and the signal
transducers and activators of transcription (STATs). Other
members of the JAK/STAT pathway are the protein tyrosine
phosphatase (SH-PTP2) and the growth-factor-receptor-
bound protein 2 (GRB2). GRB2 and SHP2 can form a
complex together with the IL-6R (gp130) and are known to
link the JAK/STAT pathway to the MAPK pathway
(Schiemann et al., 1997), which was shown recently to be
upregulated in MS (Graumann et al., 2003). Most interest-
ingly in the context of MS, the JAK/STAT-signalling pathway
plays a critical role in the regulation of the sensitivity
to cytokines and in their expression. It is known that the JAK/
STAT-signalling pathway is a sensitive switch playing a
major role in the Th-polarization of the immune system.
Members of the STAT family like STAT1, STAT3, STAT4
and STAT6 are thought to be critically involved in the
polarization of Th1, Th17 or Th2 cells (Kaplan et al., 1996;
Takeda et al., 1997; Harrington et al., 2006). In EAE, it has
been shown that STAT4-deficient mice are resistant to the
induction of MOG-induced EAE, whereas STAT6-deficient
mice show a more severe clinical course (Chitnis et al., 2001).
These findings suggest that STAT4 may be involved in
the promotion of inflammatory mechanisms, whereas
STAT6 may be important in their limitation. Therefore,
we concentrated our work on STAT4, STAT6 and their
particular downstream genes as markers for either pro-
or anti-inflammatory mechanisms in resident cells of the
brain.
In addition to the well-characterized inflammatory white
matter lesions, studies by magnetic transfer imaging (MTI)
have suggested that the normal appearing white matter
(NAWM) of the majority of MS patients has significant
abnormalities, such as blood–brain-barrier changes, axonal
injury and to some extent astro- and microgliosis (Fu et al.,
1998; Silver et al., 2001; Aboul-Enein et al., 2003). In line
with this, our recent microarray analysis of MS NAWM
revealed the upregulation of a number of functionally
related genes involved in endogenous neuroprotection, as
well as in the maintenance of cellular homeostasis
(Graumann et al., 2003). In addition to these protective
responses, the NAWM also mounts an immunomodulatory
response, which is the subject of this study.
Material and Methods
Tissue collection
MS and control tissue samples were supplied by the UK Multiple
Sclerosis Tissue Bank (UK Multicentre Research Ethics
Committee, MREC/02/2/39), funded by the Multiple Sclerosis
Society of Great Britain and Northern Ireland (registered charity
207495). Additional tissue samples were collected at the
Department of Pathology, University Hospital Basel (Ethics
Committee of the University Hospital Basel). Tissue samples
representing normal control white matter and normal-appearing
MS white matter were collected and analysed as described
previously (Graumann et al., 2003). All brains were routinely
screened by a neuropathologist to confirm diagnosis of MS and
to exclude other confounding pathologies. In particular,
Bielschowsky silver staining and b-amyloid immunostaining were
used to screen the tissues for age-related neurofibrillary tangles
and amyloid plaques. A small number of diffuse amyloid plaques
were observed in the entorhinal cortex in a number of cases,
consistent with age-related changes, but no other pathological
changes were seen. Nevertheless, additional age-related pathologies
cannot be excluded. Therefore, we performed statistical analysis
of the differentially expressed genes for age-dependent alterations.
Furthermore, NAWM tissues showing extensive T-cell infiltration
were also excluded from this study. From the 11 MS cases,
five showed a secondary-progressive, four a primary-progressive,
one a progressive-relapsing and one a silent disease course. The
mean age of the control cases was 70.4 10.7 years with a post-
mortem delay time of 17.1 5.9 h. The mean age of the MS
cases was 66.5 10.7 years with a post-mortem delay time of
11.3 5.6 h (Table 1). No statistical significant difference was
found in age of control and MS patients (P=0.387). From these
tissue blocks provided (Fig. 1A), about 20–40mg pure subcortical
white matter tissue was isolated and used for RNA isolation
(hatched area).
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Antibodies
For histochemical analysis the following antibodies were used:
anti-STAT4 (R&D Systems, Cat.Nr. PA-ST4, 1:250), anti-STAT6
(R&D Systems, Cat.Nr. AF2167, 1:250), anti-Olig2 (Chemicon,
Cat.Nr. AB9610, 1:250), anti-JAK1 (Chemicon, Cat.Nr. MAB3700,
1:250), anti-hIL-4R (R&D Systems, Cat.Nr. MAB230), anti-IL13R
(Abnova, Cat.Nr. H00003598-MO1), anti-CD68 (DAKO,
Cat.Nr.M0814, 1:500), anti-GFAP (SIGMA, Cat.Nr. G-3893),
anti-PLP (kindly provided by K.-A. Nave, Go¨ttingen), anti-MOG
(kindly provided by Dr BP Morgan, Cardiff, UK), anti-CD3
(Novocastra Labs, Cat.Nr.NCL-CD3-PS1), anti-MBP (Chemicon,
Cat.Nr. MAB386), pan neurofilaments (rabbit pAb cocktail;
Biomol, Cat.Nr.NA1297). The secondary antibodies used were:
donkey-anti-mouse-biotin (1:500), donkey-anti-rabbit-Cy2
(1:500), donkey-anti-rabbit-Cy3 (1:500), donkey-anti-rabbit-Cy5
(1:500), donkey-anti-mouse-Cy2 (1:500), donkey-anti-mouse-Cy3
(1:500), donkey-anti-rat-Cy5 (1:500), donkey-anti-goat-Cy2
(1:500) and donkey-anti-goat-Cy3 (1:500) (all from Jackson
ImmunoResearch).
Immunohistochemistry
All tissue samples were analysed by immunohistochemistry.
Cryostat sections (10 mm) used for tissue characterization using
anti-CD68, –PLP, –MOG and –CD3 antibodies were fixed for
10min in 10% formalin. Sections used for CD3 stainings were
then boiled in 10mM sodium citrate buffer, pH 6.0 for 30min.
For inactivation of endogenous peroxidase all sections were
treated with 0.3% hydrogen peroxide and blocked with blocking
buffer (1% normal donkey serum, 2% Fish skin gelatin, 0.15%
Triton). After quenching, sections were incubated with primary
antibodies overnight at 4C. Secondary biotinylated antibodies
were applied for 1 h at room temperature followed by the ABC
complex reagent (Vector Labs) for 1 h. Colour reaction was
performed with 3-amino-9-ethylcarbazole (Erne et al., 2002).
Counterstaining was performed in haematoxylin for 1min
followed by rinsing the slide in running tap water.
For fluorescent colocalization study using anti-STAT4, –STAT6,
–MBP, –OLIG2, –JAK1, –Neurofilament, –GFAP and –CD68
antibodies, cryostat sections (10 mm) were air-dried for 20min and
fixed for 10min in acetone at 20C. For MBP/JAK1 colocaliza-
tion immersed fixed tissue samples were used (fixed in 4%
paraformaldehyde in PBS for 7 days). Sections were incubated
with the primary antibodies at 4C overnight. After washing with
PBS, sections were incubated for 1 h with cupric sulfate in
ammonium acetate buffer (10mM CuSO4, 50mM CH3COONH4,
pH 5.0) in order to reduce autofluorescence (Schnell et al., 1999).
Secondary antibodies were incubated for 1 h at room temperature.
Slides were mounted with fluorosave and kept at 4C.
Total RNA preparation
Total RNA isolation was performed by homogenization in
guanidinium thiocyanate followed by a CsCl ultracentrifugation
(Bothwell et al., 1990). Freshly isolated RNA was tested for
integrity by ethidium–bromide gel electrophoresis and GFAP
Northern blot analysis as shown before (Graumann et al., 2003).
AtlasTM cDNA expression array hybridization
The Clontech AtlasTM cDNA Expression Array 1.2 (I–III) contains
3’528 selected cDNA sequences arrayed on three different
nylon membranes (1’176 per array). Array hybridization was












Cause of death Array, LC
MS patients MS1 56 f SP 31 12 Bilateral basal pneumonia I, II, III, LC
MS2 58 f PP 22 16 Peritonitis I, LC
MS3 76 f SP 414 18 Myocardial infarction I, II, III, LC
MS5 58 f PP 21 6 Bronchopneumonia I, II, III, LC
MS10 69 f PP 31 11 Acute pyelonephritis I, II, LC
MS12 78 f PP 31 9 Lung infection I, LC
MS14 56 f PR 34 6 Not known LC
MS18 78 f SP 42 5 Lung cancer I, LC
MS20 66 f SP 30 13 Aspiration pneumonia I, LC
MS25 54 f SP 20 22 Bronchopneumonia LC
MS26 83 f Silent ^ 6 Myocardial infarction I, II, III, LC
Controls CLo3 85 f ^ ^ 9 Not known LC
CLo6 73 m ^ ^ 21 Myocardial infarction I, II, III; LC
CLo7 77 m ^ ^ 26 Lung cancer I, LC
CLo8 64 f ^ ^ 18 Cardiac failure I, II, LC
CBS1 70 m ^ ^ 15 Myocardial infarction I, II, III, LC
CBS2 66 m ^ ^ 16 Lung cancer I, II, III, LC
CBS4 69 m ^ ^ 10 Myocardial infarction I, LC
CBS5 59 f ^ ^ 22 Acute pancreatitis I, II, III, LC
Clinical and pathological information concerning the 11MS and 8 control cases studied are shown. All MS and all control tissue samples
except MS25 and CLo3 were used for microarray analysis. For MS1, MS5 and CLo6 (asterisk) two different tissue blocks were used for the
microarray and qRT-PCR analysis. Abbreviations: SP=Secondary-progressive; PP=Primary-progressive; PR=Progressive-Relapsing;
Silent=clinically silent disease course; I =BD AtlasTM Human 1.2 Array I; II =BD AtlasTM Human 1.2 Array II; III =BD AtlasTM Human 1.2
Array III; LC=Lightcycler.
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performed according to Graumann et al. (2003). Array I was
hybridized with 11 MS and 8 control samples, Array II with 7 MS
and 5 control samples and Array III with 6 MS and 4 control
samples (Table 1). Quantification of differential hybridization
signal intensities was achieved with the AtlasImageTM 2.0 software
program. Data analysis was performed according to Graumann
et al. (2003). Median values showing fold changes above 1.5 were
defined indicative to be upregulated and median values below
0.66 to be downregulated in a particular MS case. To verify
gene expression data from the microarray study we performed
quantitative RT-PCR. As we described previously, qRT-PCR
results revealed an even greater fold difference, indicating
that differential expression patterns are rather under- than
overestimated from the microarray analysis (Graumann et al.,
2003).
Quantitative RT-PCR
Real-time RT-PCR was performed using the LightCycler system
(Roche). Primer sequences were either provided by Clontech or
designed from unique site over exon–intron junctions to prevent
amplification of genomic DNA. Real-time RT-PCR was performed
according to the manufacturer’s protocol (Roche). RNA amounts
were calculated with relative standard curves for all mRNAs of
Fig. 1 Histopathological examination of subcortical MS NAWM tissue. To analyse gene expression changes in the NAWM we isolated
pure subcortical white matter (hatched area) from tissue blocks (A, red box). Immunohistochemical analyses were made to characterize
the NAWM and to exclude possible lesions. NAWM stained by PLP (B) showed normal myelin. CD3 positive cells were detected rarely
in the NAWM (C, arrow).We could detect some CD68 positive cells in the NAWM (D, arrows). Furthermore, staining for GFAP revealed
weakly activated astrocytes (E). Bars=50mm.
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interest and 60s ribosomal protein L13A was used for normal-
ization. Normalization was further evaluated by the 40s ribosomal
protein S9. Primer sequences used for qRT-PCR are shown in
Table 2.
In situ hybridization
cDNA sequences of STAT6 (U16031, pos. 1248–2522) and HIF-1a
(U22431, po. 1215–2394) were cloned from human cerebellum
tissue into pBluescript KS II+. cDNA for HLA-DRa was kindly
provided by Viktor Steimle (Department of Biology, University
of Sherbrooke, Sherbrooke, Canada). Digoxigenin-labelled
cRNAs were generated for Hif-1a and HLA-DRa. In situ
hybridization was performed on cryosections (10 mm thick) of
freshly frozen tissue as described previously (Schaeren-Wiemers
and Gerfin-Moser, 1993; Spiegel et al., 2002). Hybridization was
done overnight at 68C and colour reaction time for the alkaline
phosphatase reaction was 48 h for all probes.
Statistics
Statistical significance is expressed by P-values generated by
the non-parametric Mann–Whitney U-Test. For each gene two
P-values were calculated (Table 3). A hierarchical cluster analysis
was performed using the program ‘Cluster’ and ‘TreeView’ from
Michael Eisen (Eisen et al., 1998). Hierarchical cluster analysis
revealed two MS case groups based on similarities in their gene
expression pattern. Therefore, two P-values were calculated. The
first P-value (marked by an asterisk) was calculated using the
signal intensities from the cases MS 1, 2, 3, 5, 12 and 26, whereas
the second P-value (marked by double-asterisk) was calculated by
using all MS cases. To evaluate differential gene expression data
from the microarrays in more detail, a boxplot from each gene
was generated and analysed (data are shown for particular genes in
Fig. 5). For this, the hybridization signal intensities were
normalized to one of the control samples according to
Graumann et al. (2003). Statistical correlation was calculated
using the non-parametric Spearman’s test.
Table 2 Primer sequences used for qRT-PCR
Primer name Gene accession number Sequence
50 STAT4 NM_003151.2 50 -TCCGAAGTGATTCAACAGAGCC-30
30 STAT4 50 -TTCTTGGTGCGTCAGAGTTTATCC-30
50 STAT6 NM_003153.3 50 -CACTGGAAGCAGGAAGAACT-30
30 STAT6 50 -TCAAGCTGTGCAGAGACACT-30
50 SOCS3 NM_003955.3 50 -TGTGCCTCCTGACTATGTCT-30
30 SOCS3 50 -CCTGACTGGCCAATACTTAC-30
50 Aqp4 NM_001650.4 50 -TACTGGTGCCAGCATGAATC-30
30 Aqp4 50 -TTGTCCTCCACCTCCATGTA-30
50 HLA-DR K01171 50 -ATGGCCATAAGTGGAGTCC-30
30 HLA-DR 50 -TTCACTGAGGTCAAGGATTG-30
50 nNOS NM_000620.1 50 -TGGAGGTGCTGGAGGAGTTC-30
30 nNOS 50 -TGAGCCAGGAGGAGCATACG-30
50 MAG NM_080600.1 50 -CCGCCGAAGACGGCGTCTATGC-30
30 MAG 50 -CTCTCGTAGATGACCGTGGACAGG-30
50 MOG NM_002433.3 50 -CCTCCTCCTCCTCCAAGT-30
30 MOG 50 -CCATGCCTGTAGCGTTCTTC-30
50 PLP NM_000533.3 50 -TTCTGTGGCTGTGGACATG-30
30 PLP 50 -GAGGCAGTTCCATAGATGAC-30
50 MBP M30515 50 -ACCCGGCAAGAACTGCTCACTATGGCTC-30
30 MBP 50 -TGAGCCGATTTATAGTCGGACGCAC-30
50 GFAP J04569 50 -GACGAGATGGCCCGCCACTTGC-30
30 GFAP 50 -CTCCACGGTCTTCACCACGATGTTC-30
50 NSE NM_001975.2 50 -TGGTGTGCTGAGGTGTTAG-30
30 NSE 50 -CCTTATTAGCCAGGCGTGA-30
50 Snap25 XM_009497 50 -TAGTGGACGAACGGGAGCAGATGG-30
30 Snap25 50 -CGTTGGTTGGCCTCATCAATTCTGG-30
50 PDGFR-alpha NM_006206.2 50 -CCACGCTACCAGTGAAGTCT-30
30 PDGFR-alpha 50 -CACAGCAGGATGGTCACTCT-30
50 60s X56932 50 -TCGTGCGTCTGAAGCCTAC-30
30 60s 50 -TCTTCCGGTAGTGGATCTTG-30
50IL-4 NM_000589.2 50 -CCGAGTTGACCGTAACAGAC-30
30IL-4 50 -CTCTGGTTGGCTTCCTTCAC-30
50IL-4R NM_000418.2 50 -CGTCAGCGTTTCCTGCATTG-30
30IL-4R 50 -CTCTTTGGCAGCCTTGTGAG-30
50IL-12p40 NM_002187.2 50 -AACCTGACCCACCCAAGAAC-30
30IL-12p40 50 -AGATGCCCATTCGCTCCAAG-30
50IL-13 NM_002188.2 50 -ATCCGCTCCTCAATCCTCTC-30
30IL-13 50 -AGCATCCTCTGGGTCTTCTC-30
50 and 30 primers used for quantitative RT-PCR analysis together with the gene accession numbers are shown.The gene 60s
was used as housekeeping gene for normalization.
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Table 3 Microarray analysis. List of differentially expressed genes in NAWM
Upregulation is shown in dark grey whereas downregulation is shown in yellow.Medians of ratios against all control samples are shown for
each MS sample. Statistical significance is expressed as P-value (non-parametric Mann^Whitney U-test). P-values were calculated for the
major group () and for all MS cases (). P-values below 0.05 are printed in bold numbers, whereas P-values between 0.05 and 0.1are shown
in italic numbers.
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Results
Histological and molecular examination
of subcortical NAWM from MS and
control brains
All brains used in this study were routinely screened by a
neuropathologist to confirm diagnosis of MS and to
exclude confounding pathologies, in particular neurofibril-
lary tangles and amyloid plaques. The clinical and
pathological information on the MS and control cases
was collected and is summarized in Table 1. To analyse
gene expression changes in the NAWM, we dissected
subcortical white matter from cortical grey matter to ensure
that only RNA from white matter tissue was isolated
(Fig. 1A, hatched area). Isolated RNA was tested for its
integrity by ethidium–bromide gel electrophoresis and
GFAP Northern blotting, and only samples with high-
quality RNA were used. In order to confirm normal cellular
integrity and composition, and to exclude any possible
pathological changes such as demyelination and inflamma-
tion, we performed immunohistochemical analysis on the
NAWM tissue. Staining for myelinated fibres (Fig. 1B, PLP)
showed no signs of demyelination or shadow plaques. As
tissues with extensive T-cell infiltration were excluded from
this study, we detected almost no CD3-positive cells in
subcortical NAWM (Fig. 1C). However, we detected CD68
positive cells distributed throughout the MS NAWM
(Fig. 1D). There was no evidence of astrogliosis as revealed
by an anti-GFAP staining (Fig. 1E, GFAP). As we have
described before, some neurons were found in human
subcortical white matter as well (Graumann et al., 2003).
In summary, all tissue included in this study showed no
histological evidence of demyelinating lesions, remyelina-
tion or inflammatory infiltrates.
In a recent study, we performed a differential expression
analysis of subcortical NAWM from MS cases and cor-
responding subcortical white matter from control cases
(Graumann et al., 2003). We performed a hierarchical
cluster analysis to identify groups of MS cases based on
similarities in their gene expression pattern. This analysis
revealed a major group within the MS cases (MS1, 2, 3, 5,
12 and 26), which showed strong similarities in their
expression patterns (Graumann et al., 2003). A minor
group of three MS cases (MS10, 18 and 20) showed an
expression pattern with some similarities to the major
group such as the upregulation of STAT6, but showed
overall fewer alterations compared to the control cases.
Changed expression of genes of the
JAK/STAT-signalling pathway
One of the major pathways involved in immune regulation
is the JAK/STAT-signalling pathway (Dell’Albani et al., 2003).
By microarray and quantitative RT-PCR analysis of
MS NAWM, we observed changes in the regulation of
gene expression of several genes known to be involved in
the JAK/STAT-signalling pathway (Table 3, Fig. 2A–D). One
member of the STAT family, STAT6 was upregulated in all
MS cases (Table 3, Fig. 2A, P= 0.005). Furthermore, we also
found STAT3 to be significantly upregulated in these
MS NAWM (Table 3). The other members, STAT1, 2, 4, 5a
and 5b could not be detected by microarray analysis.
However, using the more sensitive qRT-PCR, we revealed
that STAT4 was also significantly upregulated in MS
cases (Fig. 2D, P= 0.002). To identify the cell types expressing
STAT4 and STAT6, we performed a immunofluorescent
colocalization study (Figs 3 and 4). Most of the STAT4
expressing cells were CD68-positive, suggesting that the main
cell population expressing STAT4 are activated microglia
(Fig. 3A, arrow). Occasionally, we identified STAT4-positive
astrocytes (Fig. 3B, arrow). We did not detect any STAT4-
positive oligodendrocytes or neurons in MS NAWM. In
contrast, immunofluorescent staining for STAT6 showed that
STAT6 was mostly in cells expressing OLIG2 (Fig. 4A,
arrows), demonstrating that cells of the oligodendrocyte
lineage were the main cell population expressing this tran-
scription factor. The arrangement of STAT6/OLIG2-positive
cells in interfascicular rows indicates an expression by
myelinating oligodendrocytes. However, STAT6 expression
was not limited to oligodendrocytes, as occasionally GFAP/
STAT6-positive astrocytes were also detected in the NAWM
(Fig. 4B, arrow). Colocalization with neurofilament revealed
STAT6/neurofilament-positive neurons in the NAWM as well
(Fig. 4C, arrow). No colocalization of STAT6 together with
CD68 could be detected. Triple immunofluorescence staining
showed sporadically astrocytes positive for both STAT4 and
STAT6 in the NAWM (Fig. 4D, arrow).
The expression of all four members of the JAK family
could be detected by microarray analysis. Whereas JAK2
and TYK2 were not statistically significant changed, JAK1
was significantly upregulated in the NAWM of MS cases
(Table 3, Fig. 2B). Another member of the JAK tyrosine
kinase family, JAK3, was also upregulated in MS NAWM
but with a weaker significance (Table 3). To identify the cell
types expressing JAK1, we performed a colocalization
immunofluorescent study, which revealed the expression
of JAK1 in oligodendrocytes expressing MBP (Fig. 4E,
arrow). Interestingly, we could show a positive correlation
of JAK1 (r= 0.505, P= 0.027) and JAK3 (r= 0.530,
P= 0.020) expression levels to the expression levels of
STAT6 within the different MS cases. Although an overall
increase in expression of JAK2 and TYK2 in MS could also
be observed, the upregulation was not statistically signifi-
cant. Other genes belonging to the JAK/STAT-signalling
pathway, such as SH-PTP2 and GRB2 were also significantly
upregulated in MS NAWM (Table 3). Furthermore, we found
the upregulation of neuroblastoma RAS viral (v-ras)
oncogene homolog (N-RAS), v-raf-1 murine leukaemia
viral oncogene homolog 1 (c-raf) in some and mitogen-
activated protein kinase kinase 1 (MAPKK1) in most MS
cases. Also, cyclin-dependent kinase inhibitor 1A (p21,
WAF1) and FK506-binding protein 12-rapamycin-associated
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protein 1 (FRAP1) were upregulated in the majority of the
MS cases. In summary, our results show the upregulation of
genes from the Interleukin-4/Interleukin-13-signalling path-
way expressed by oligodendrocytes and genes of other JAK/
STAT-signalling pathways in resident brain cells in a majority
of the MS cases studied.
Upregulated cytokine and cytokine-receptor
expression in NAWMof MS patients
Changes in the balance between pro- and anti-inflamma-
tory cytokines and their receptors have been implicated in
the pathogenesis of MS. Therefore, we investigated the
expression pattern of cytokines and their receptors in the
NAWM of MS patients (Table 3). Most strikingly, we
observed a significant upregulation of the anti-inflamma-
tory cytokines interleukin 10 (IL-10) and transforming
growth factor beta 2 (TGF-b2) in the MS cases. On the
other hand, IL-18 and IL-1b also showed elevated
expression levels in the majority of MS cases. Other
cytokines such as TGF-a and TGF-b3 showed only minor
changes or were even decreased in some MS cases (data
not shown). An endogenous expression of most of the
cytokines, in particular IL-4, IL-6, IL-12, IL-13, IL-17, IL-23
and IFN-g could not be detected by microarray analysis or
by quantitative RT-PCR.
Microarray analysis of cytokine receptors revealed
detectable expression of IL-2 receptor subunit alpha
Fig. 2 Boxplots of selected differentially expressed genes analysed by quantitative RT-PCR and microarray. qRT-PCRwas performed for
STAT6 (A), IL-4R (C), STAT4 (D), HIF-1a (F), nNOS (G), iNOS (H) and eNOS (I). JAK1 (B) and MCSF (E) were analysed by microarray.
Boxplots show differential gene expression in control white matter and MS NAWM.Genes significantly upregulated in MS NAWM are
marked with an asterisk.
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(IL-2Ra), IFN-greceptor, IFN-alpha/beta receptor, IL-6
receptor (IL-6R) and tumour necrosis factor receptor 1
(TNFR1; Table 3). We detected an upregulation of the
IL-6Rb subunit (gp130) and TNFR1 in 9 out of 11 MS
samples. In contrast to IL-6Rb, which was significantly
upregulated in MS NAWM, upregulation of TNFR1 was
not statistically significant due to the fact that several
control samples had also relative high TNFR1 expression
levels (Table 3). One of the most consistently upregulated
cytokine receptors was the interleukin-2-receptor alpha
(IL-2Ra). Its co-receptors IL-2Rb and IL-2Rg, however,
could not be detected by microarray (data not shown).
Significant upregulation was also detected for the IFN-a/b
receptor, whereas the IFN-g receptor was only upregulated
in 2 of 11 MS samples (Table 3).
To investigate the anti-inflammatory-signalling pathway
of STAT6, JAK1 and JAK3 in more detail, we examined the
expression pattern of one of its main receptors, the IL-4
receptor (IL-4R), by quantitative RT-PCR. We detected
elevated expression levels of IL-4R in MS NAWM (Fig. 2C).
Even though we could detect an overall higher expression
of IL-4R in MS NAWM samples this was not statistically
significant. The reason for this is a relative high expression
of one of the controls (CLo6), and in addition, a moderate
expression of IL-4R in the three cases of the minor group.
However, IL-4R expression levels correlated well with
the expression levels of STAT6 (r= 0.657, P= 0.008)
within the analysed tissue samples. Immunofluorescent
colocalization study with STAT6 revealed STAT6/IL-4R
positive oligodendrocytes throughout the NAWM (Fig. 4F).
Furthermore, immunofluorescent colocalization study for
IL-13 receptor (IL-13R), which is another STAT6-activating
receptor, revealed STAT6/IL-13R positive oligodendrocytes
in the MS NAWM as well (Fig. 4G). In summary, our
results show that oligodendrocytes in MS NAWM are




in NAWMof MS patients
Chemokines and chemokine receptors play a critical role
in the recruitment of lymphocytes and other inflammatory
cells into the CNS (Sospedra and Martin, 2005). Microarray
analysis revealed significant upregulation of several chemo-
kines in MS NAWM (Table 3), in particular chromogranin
C, monocyte colony-stimulating factor (MCSF) and
endothelial-monocyte-activating polypeptide (EMAP-II).
Boxplot analysis for MCSF shows an overall low-level
expression in control cases and upregulation in almost
all MS cases (Fig. 2E). Although monocyte chemotactic
protein (MCP-1) showed an upregulation in all MS cases of
the major group (Table 3), this was not statistically
significant because MCP-1 expression among control cases
was highly variable (data not shown). Other chemokines
such as RANTES and its receptor CCR1 also showed
elevated expression levels in particular MS cases, but for the
same reason as for MCP-1 these were not statistically
significant. Altogether, we could demonstrate that the
expression levels of several chemokines involved in the
attraction of peripheral immune cells into the CNS were
increased.
Differential gene expression
of cell adhesion molecules
Cell adhesion molecules play an essential role in many
inflammatory processes, such as blood–brain-barrier
changes, cell migration and differentiation. Therefore,
Fig. 3 Immunofluorescence localization of STAT4 in MS NAWM.Colocalization analysis showed STAT4 being expressed in CD68 positive
cells (A). Furthermore, we could show some astrocytes positive for STAT4 (B).We did not detect any neurons or oligodendrocytes positive
for STAT4 in the NAWM. Bar=20mm.
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Fig. 4 Immunofluorescence localization of STAT6 and JAK1 in MS NAWM. STAT6 was mostly colocalized together with the
oligodendrocytes marker OLIG2 (A). In few cases colocalization with astrocytes (B) and subcortical white matter neurons (C) could
be observed. Sporadically, we could detect some astrocytes positive for both, STAT4 and STAT6 (D). Additionally, we could show that
JAK1mostly colocalized together with the myelin protein MBP (E). Furthermore, IL-4R (F) and Il-13R (G), the main receptors leading
to STAT6 activation, were detected to colocalize with STAT6 and OLIG2. Bar=20mm.
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we investigated the gene expression profile of different cell
adhesion molecules (Table 3). Most of these genes did not
show altered expression levels with the exception of ICAM-
1, which was significantly upregulated in the majority of
the MS cases (Table 3). Others such as LFA-1b had a
more heterogeneous expression pattern (Table 3). Matrix
metalloproteinases (MMP) are also implicated in the
pathogenesis of the inflammatory process in MS, but our
microarray study revealed that only MMP-11 (stromelysin-
3) was upregulated in MS NAWM. MMP-7, MMP-9
and MMP-16 were found constitutively expressed in all
control and MS cases, but their expression levels were not
altered.
Upregulation of HLA-DRa in MSNAWM
The expression of the major histocompatibility complex
HLA-DR a-chain, crucial for antigen presentation, was
upregulated in the majority of MS cases, whereas upregu-
lation of HLA II DP a-chain was less evident and only
detected in a subset of MS cases (data not shown).
To identify cells expressing HLA-DRa, we performed
in situ hybridization analysis. This revealed the expression
of HLA-DRa mRNA throughout the NAWM of the
majority of MS cases (Fig. 5A), whereas in control white
matter HLA-DRa was not detectable (Fig. 5B). Due to the
morphology of the HLA-DRa expressing cells—small cells
with thin processes—we identified most of the HLA-DRa
expressing cells as microglia (Fig. 5C). Colocalization with
anti-GFAP immunohistochemistry revealed that some
astrocytes might also express HLA-DRa (data not shown).
In summary, our data indicate that a part of the HLA Class
II complex, especially HLA-DRa, is upregulated in MS
NAWM.
Upregulation of the neuronalçbut not
of the inducible and endothelial nitric
oxide synthase
Nitric oxide (NO), and thus nitric oxide synthases (NOS)
play an important role under physiological as well as
pathological conditions (Smith and Lassmann, 2002).
Therefore, we performed qRT-PCR analysis and detected
upregulation of the neuronal form of NOS (nNOS), in
most of the MS NAWM tissue samples (Fig. 2G). In
contrast, the inducible NOS (iNOS) showed comparable
expression levels in MS NAWM as in controls cases
(Fig. 2H). Also the expression of endothelial NOS (eNOS)
in MS NAWM showed no difference to the control cases
(Fig. 2H and I).
Fig. 5 In situ hybridization of HLA-DR mRNA in MS and control white matter. Many HLA-DRa positive cells were detected in the
NAWM of MS cases (A) compared with white matter from control cases where the hybridization signal was below background
levels (B). In situ hybridization shows that HLA-DRa mRNA expression in cells of the NAWM morphologically alike microglia cells
(C, arrows). Bar=50mm.
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Upregulation of HIF-1a in NAWM
In our previous microarray study we showed that HIF-1a,
a key regulator of hypoxia-induced gene regulation, and its
downstream genes were significantly upregulated in MS
NAWM (Graumann et al., 2003). Quantitative RT-PCR
analysis in 11 MS and 8 control cases for HIF-1arevealed
a consistent upregulation of HIF-1a in MS NAWM
(Fig. 2F, P= 0.002), verifying our microarray data
(Graumann et al., 2003). In order to identify the cell
types expressing HIF-1a, we performed in situ hybridization
analysis (Fig. 6). We found that in subcortical white matter
of control cases HIF-1a mRNA could not be detected
(Fig. 6A), indicating an overall weak expression in white
matter. However, in MS NAWM HIF-1a hybridization
signals became detectable in a number of cells throughout
the NAWM (Fig. 6B, arrows). Colocalization analysis for
GFAP revealed that a small subpopulation of astrocytes
expressed HIF-1a (Fig. 6C). Other HIF-1a positive cells
were arranged in interfascicular rows, suggestive of
myelinating oligodendrocytes (Fig. 6D, arrows).
Discussion
Very little is known about the earliest intrinsic changes to
the CNS occurring in MS before the appearance of overt
inflammatory and demyelinating plaques. The normal
appearing non-lesional white matter looks normal from a
morphological and cellular point of view. However,
MRI and gene expression studies have shown significant
changes in NAWM that might give indications concerning
both, the early changes occurring before lesion formation
and the attempts by the CNS to prevent the same (Fu et al.,
1998; Silver et al., 2001; Aboul-Enein et al., 2003;
Graumann et al., 2003). Furthermore, most recent data
suggests a diffuse inflammatory damage spreading through-
out the whole brain in the chronic phase of the disease
associated with slow progressive axonal injury at sites
without inflammation (Kutzelnigg et al., 2005). In order to
identify pre-lesional changes and immunological regulators,
we analysed the gene expression profile in the NAWM of
11 MS cases. All tissues included in this study were
routinely screened by a neuropathologist and showed no
signs of additional neurological diseases. Tissues from
MS cases with obvious confounding pathologies, in
particular neurofibrillary tangles and amyloid plaques
were excluded. Furthermore, to test whether the tissue
used in this study show signs of age-related confounding
pathologies, we correlated gene expression changes with age
but found no statistical significant correlations; e.g. STAT6
(r= –0.386, P= 0.103), STAT4 (r=–0.440, P= 0.116), JAK1
(r= –0.386, P= 0.103), JAK3 (r=–0.258, P= 0.286) and
IL-4R (r= –0.121, P= 0.668). Additionally, there is no
statistical significant difference in age between the MS
Fig. 6 In situ hybridization of HIF-1amRNA in MS and control white matter. In subcortical white matter of control cases HIF-1a could
not be detected (A). In MS NAWM, however, we could detect a hybridization signal for HIF-1amRNA in a number of cells (B).
Colocalization with anti-GFAP immunohistochemistry revealed a subpopulation of astrocytes expressing HIF-1a (C, arrow), whereas
other astrocytes were negative for HIF-1a (C, arrowhead). Due to the chain-like arrangement and their morphology, we suggest that
Hif-1a is also expressed by oligodendrocytes (D, arrows). Bars=25mm.
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and the control group, which further minimizes possible
influence of age-related pathology. In particular, NAWM
tissues with extensive T-cell infiltration were also excluded
from this study. Thus, T-cell-specific transcripts were rarely
detectable in single MS cases and no correlation of genes
from the STAT-signalling pathways and T-cell-specific
transcripts could be made. In addition, we could not
detect any CD3/STAT6-expressing cells in MS NAWM.
As gene expression changes were obtained by comparing
MS cases with age-matched control cases, detection of
differential gene expression due to age-related mechanisms
was avoided. This so defined NAWM tissue is ideal to study
the intrinsic changes of brain cells during the long-lasting
disease course of MS.
Hierarchical cluster analysis of the MS cases based on the
similarities of their expression pattern revealed two possible
groups. But no grouping according to the MS type could be
detected. Possibly, gene expression changes in the MS
NAWM from different MS types might equalize during the
long-lasting disease course. As gene expression changes
taking place in the MS NAWM do not depend upon the
MS type, this allowed us to analyse gene expression data
from all MS types together.
Altogether, our analysis revealed that genes involved
at different levels of the inflammatory response, such as
signalling, transcription, cell adhesion and antigen presenta-
tion, were upregulated in the MS NAWM. Most interestingly,
we detected upregulation of genes linked to both anti- as well
as pro-inflammatory mechanisms. Two central players
involved in these two mechanisms are the transcription
factors STAT6 and STAT4 (Pfitzner et al., 2004).
Diffuse damage of the CNS might be
due to pro-inflammatory microglia
in the MSNAWM
We found that in the NAWM, STAT4, a characteristic
marker for pro-inflammatory mechanisms, was generally
expressed by CD68-positive cells suggestive for activated
microglia and occasionally astrocytes. In line, an upregula-
tion of HLA-DRa, known to be generally expressed by
microglia, was detected in the NAWM of MS cases. STAT4
is involved in IL-12 and IL-23-mediated signalling and as a
consequence in Th1 cell differentiation (Watford et al.,
2004). The upregulation of STAT4 found in the NAWM
tissue is strikingly prominent and might point to the
development of a pro-inflammatory environment allowing
or facilitating the infiltration of peripheral immune cells
into the CNS. This is supported by a study investigating the
role of STAT4 in the development of local allergic airway
response. In this study, STAT4 knockout mice showed
a significant decrease in airway hyperreactivity via local
alteration of chemokine production, such as CCL5, CCL6,
CCL11 and CCL17 (Raman et al., 2003). Furthermore
STAT4 is known to play a major role in IFN-g regulation
and is involved in the induction of IL-2R (Watford et al.,
2004). Also involved in IL-12 and IL-23 signalling are the
Janus kinases JAK2 and TYK2, which were upregulated
in some MS cases. Furthermore, IL-1b, which is described
as a pro-inflammatory cytokine primarily secreted by
activated microglia cells and infiltrating macrophages
(Correale and Villa, 2004) was significantly upregulated
in MS NAWM. An enhanced expression of IL-1b might
also be one cause of the reported diffuse damage of the
CNS (Kutzelnigg et al., 2005), as intracerebral microinjec-
tions of IL-1b induced death of intrinsic CNS cells (Holmin
and Mathiesen, 2000). The view of microglia playing a pro-
inflammatory role in MS NAWM is further supported by
a study showing that a blockage of microglial release
of nitrite oxide, pro-inflammatory cytokines and chemo-
kines, resulted in a strong reduction of CNS inflammation
and an amelioration of the clinical signs in EAE (Heppner
et al., 2005). Furthermore, in MS NAWM, we could detect
the upregulation of several chemokines, such as MCSF,
EMAP II, MCP-1 (CCL2), ICAM-1 and RANTES (CCL5).
This is inline with a study which showed an increased
MCSF expression in the periplaque white matter of MS
cases (Werner et al., 2002). Altogether, we speculate that
the alteration of the pro-inflammatory gene expression
pattern in resident cells of the NAWM, most likely
microglia, could prepare or later contribute to the enhance-
ment and facilitation of the infiltration of active immune
cells into the CNS. At this point, the production of
these pro-inflammatory signals might still not be enough to
promote T-cell recruitment but they might be already
deleterious for the CNS, as the expression of one specific
cytokine under certain circumstances can already lead
to an infiltration of immune cells into the CNS (Chiang
et al., 1996).
Are oligodendrocytes playing an active
role in immune regulation in the CNS?
A major finding of this study was the upregulation of
genes involved in anti-inflammatory mechanisms in
MS NAWM, illustrated by the upregulation of IL-10, a
potent anti-inflammatory cytokine known to inhibit the
activation of monocytes, dendritic cells and macrophages
(Beebe et al., 2002). Furthermore, TGF-b2, which was
reported to reduce demyelination and macrophage recruit-
ment in a viral model of MS (Drescher et al., 2000), was
strongly upregulated in NAWM of most of the MS cases.
However, most interesting was the finding that STAT6 was
upregulated in the NAWM of all MS cases. Although
the function of STAT6 is not yet fully determined, this
transcription factor is known to be involved in anti-
inflammatory pathways. STAT6 is one of the major steps
in IL-4 and IL-13 signalling (Takeda et al., 1997) and this is
further demonstrated by the exacerbation of EAE in
STAT6-deficient mice (Chitnis et al., 2001). The main
cells expressing STAT6 in the MS NAWM were found to be
oligodendrocytes. Furthermore, JAK1, IL-4R and IL-13R,
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all belonging to the STAT6-signalling pathway (Hebenstreit
et al., 2006), were also expressed by oligodendrocytes.
In the case of JAK1 and IL-4R, this is in agreement with
the findings of Cannella and Raine (2004). Comparison of
the expression pattern of STAT6, IL-4R, JAK1 and JAK3
showed a strong correlation within the different cases. This
suggests an overall upregulation of the STAT6-signalling
pathway in oligodendrocytes. Additionally, we show that
HIF-1a, a transcription factor inducing hypoxic precondi-
tioning (Bergeron et al., 2000), is also expressed in
oligodendrocytes in MS NAWM. Therefore, we hypothesize
that in contrast to the pro-inflammatory response,
the protective, anti-inflammatory response in the NAWM
is mounted predominantly by oligodendrocytes. This
conclusion is supported by a recent study showing that
oligodendrocytes are capable of mounting protective
mechanisms preventing demyelination (Lin et al., 2007).
Furthermore, it was recently reported that mice with
suppressed oligodendrocyte responsiveness to IFN-g devel-
oped EAE with an accelerated onset and markedly increased
oligodendrocyte apoptosis (Balabanov et al., 2007). In the
same study, oligodendrocytes were shown to be capable
of expressing several chemokines. This supports the view
of oligodendrocytes participating in the regulation of
CNS intrinsic immunity. Therefore, we speculate that
the exacerbation of EAE in STAT6 knockout mice
(Chitnis et al., 2001) might also result from the deficiency
in activating the STAT6-signalling pathway in oligoden-
drocytes. Because oligodendrocytes are highly susceptible to
inflammation-mediated damage it may be crucial for them
to compensate for the upregulated pro-inflammatory
environment and to limit the inflammatory response
and damage. The upregulation of an anti-inflammatory,
and therefore also neuroprotective, environment in the MS
NAWM is further supported by the activation of other
neuroprotective pathways shown in our previous NAWM
study (Graumann et al., 2003).
Are signals from lesions leading to an
imbalance of inflammatory mechanisms
in NAWMor vice versa?
We hypothesize that there are two possible reasons for the
differential regulation of immune modulating genes in the
cells of the NAWM. One possibility could be that diffusing,
soluble factors released by activated inflammatory cells
found in active MS lesions might activate and modulate
inflammatory gene expression in resident cells of the distant
NAWM. This idea is supported by a study using quan-
titative magnetic resonance imaging (MRI) techniques,
where the authors suggest that axonal damage and demy-
elination in NAWM mainly arise as a secondary result of
visible lesions with the largest effect close to these lesions
(Vrenken et al., 2006). With the exception of IL-1b, IL-10,
IL-18 and TGF-b2, most cytokines could not be detected by
microarray in MS NAWM, which suggests that these
cytokines are not, or very weakly, expressed in NAWM
tissue. Because we observed STAT4 and STAT6 upregula-
tion in MS NAWM, we performed quantitative RT-PCR to
identify the possible expression of their main activating
cytokines, IL-4, IL-13, IL12 and IL-23. The absence of IL-4,
IL-12, IL-13 and IL-23 expression on one hand, and the
simultaneous upregulation of genes from the STAT4 and
STAT6 pathway in MS NAWM on the other hand, further
imply that extrinsic signals might influence the expression
of immune modulating genes in the resident cells of the
CNS. Additionally, this might be supported by the fact that
in different tissue samples from the same MS case some
genes are differently regulated, such as MCSF or CCR1 in
the case of MS1.
Another possibility could be that brain intrinsic events
such as impairment of oligodendrocyte and/or neuronal
function, and subsequent astrocyte and microglia activation
may be the initial cause for the differential gene regulation
observed in NAWM. This hypothesis is supported by the
upregulation of the endogenous neuronal NOS (nNOS),
but not of the inducible NOS (iNOS) and endothelial NOS
(eNOS), suggesting a parenchymal disregulation. Immune
modulating signals from the periphery would first activate
microglia inducing iNOS or endothelial cells of the blood–
brain-barrier activating eNOS. Moreover, the upregulation
of HIF-1a in oligodendrocytes and neurons supports the
view of oligodendrocyte and/or neuronal dysfunction in the
NAWM as a possible primary cause. This idea is supported
by a study of relapsing–remitting MS cases, showing wide-
spread oligodendrocyte apoptosis as the earliest change in
lesions in which other cells appeared normal (Barnett and
Prineas, 2004). It could be that in certain regions of the
NAWM activated endogenous neuroprotective mechanisms
may gradually fail. This may lead to an imbalance between
protective and pro-inflammatory mechanisms facilitating
lesion formation.
Is MSNAWM in a subtle
balance between inflammation
and neuroprotection?
Overall our results suggest that although the NAWM of
MS patients shows no visible signs of active inflammation,
many different genes are expressed in the tissue, which
are known to be involved in the regulation and activation
of the immune response that are normally not expressed
in the CNS. The expression of pro- as well as anti-
inflammatory genes in the NAWM of the MS brain suggests
that the CNS is in a state of low-level inflammation and
an unsteady balance between protection and inflammation.
This is further reflected by the heterogeneous regulation
of cell adhesion molecules, matrix metalloproteinases
and genes of the HLA complex. Yet, this combination of
inflammatory factors seems not to be enough to promote
T-cell recruitment. Possibly, these immune modulating
genes are expressed below an active threshold or not in
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the required combination. The expression of the different
subunits of the interleukin 2 receptor may also suggest that
some of these mechanisms are not yet functionally active.
Furthermore, the presence of competing anti-inflammatory
mechanisms may inhibit infiltration of peripheral immune
cells. Nevertheless, the activation of pro-inflammatory
components might contribute to the reported diffuse
damage of the CNS in MS (Kutzelnigg et al., 2005).
In summary, we show that a substantial set of genes
involved in inflammation is expressed in resident cells of
the NAWM. These genes are specifically regulated in the
NAWM of MS patients compared with healthy controls,
indicating an activation of the intrinsic immune regulation
of the CNS, whereat oligodendrocytes actively participate.
Therefore, the MS NAWM may be in a state of subtle
balance between inflammation and neuroprotection, leading
to an immune preconditioning of the non-infiltrated
NAWM.
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